Open Nav

Ortwin Ertl, MBA


Annikki GmbH
  • Industry:Biochemicals

Ortwin Ertl founded Annikki GmbH in 2007 and is its CEO. Annikki has two lines of business -- redox biocatalysis and biomass fractionation. It also spun off a company, Treemera GmbH, that is scaling a process to make Furan Dicarboxylic Acid (FDCA). In 1999 he founded IEP GmbH and was its CEO until 2006. IEP developed into a profitable technology company with a focus on bio-reduction processes to produce chiral hydroxy compounds. From 1995 to 1999 Mr. Ertl was consultant for several biotechnology companies, he headed Phyton GmbH, which was engaged in scale-up activities for the manufacture of Paclitaxel (a leading cytostatic drug) and prepared the foundation of IEP. From 1993 to 1995 he worked in marketing of pharmaceutical active ingredients and in technology marketing with Helm AG, Hamburg. After finishing his studies with an MBA in business administration at the Vienna University of Economics he studied business Japanese in Tokyo in 1991/92.

This speaker's sessions: